UOTTAIMCU
CPRX

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Catalyst Pharmaceutical CPRX Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Sell
9,346
-18,030
-66% -$532K 0.03% 138
2026
Q1 		$678K Sell
27,376
-12,059
-31% -$287K 0.1% 103
2025
Q4 		$920K Buy
+39,435
New +$878K 0.13% 96

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s CPRX Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) reduced its Catalyst Pharmaceutical (CPRX) stake by 66% in Q2 2026, selling an estimated $532K and leaving 9,346 shares worth $294K. The position accounts for 0.03% of the portfolio, ranked #138.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in CPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $920K in Q4 2025. 244 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) held 9,346 shares of Catalyst Pharmaceutical worth $294K as of Q2 2026.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 18,030 Catalyst Pharmaceutical shares in Q2 2026, an estimated $532K.
  • Catalyst Pharmaceutical made up 0.03% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #138 holding.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Catalyst Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Catalyst Pharmaceutical position peaked at $920K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.